You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (93)

Journals (0)

1-10 of 93 results for anti-PD-1/PD-L1 inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Retricted access

Review article

First published 2021-8

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Select article: PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway

Open access

Research article

First published 2024-5

PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway

Sixu Zhou, Baogui Wang, Yingying Wei [...]

Cancer Biomarkers

Select article: Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis

Open access

Research article

First published 2025

Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis

Linjing Zhou, Yuwei Li, Le Wang [...]

Therapeutic Advances in Medical Oncology

Select article: Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Open access

Research article

First published 2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional,propensity score-matching cohort analysis

Qiaofeng Zhong, Longfeng Zhang, Lin Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study

Retricted access

Article commentary

First published 2019-4

Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study

Sarbajit Mukherjee, Sami Ibrahimi, Bilal Khalid [...]

Journal of Oncology Pharmacy Practice

Select article: Clinical assessment of immune-related adverse events

Open access

Review article

First published 2018

Clinical assessment of immune-related adverse events

Aaron Sosa, Esther Lopez Cadena, Cristina Simon Olive [...]

Therapeutic Advances in Medical Oncology

Select article: Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions

Retricted access

Research article

First published 2019-6

Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions

Bellinda L King-Kallimanis, Lynn J Howie, Jessica K Roydhouse [...]

Clinical Trials

Select article: The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Open access

Review article

First published 2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Jingjing Qu, Quanhui Mei, Li Liu [...]

Therapeutic Advances in Medical Oncology

Select article: Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Open access

Research article

First published 2022-11

Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Takashi Inoue, Mamoru Narukawa

Cancer Control

Select article: PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy

Free access

Research article

First published 2014-7

PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy

Dawn E. Dolan, Shilpa Gupta

Cancer Control

1
2
3
•••
10
10 / page

Article type

Publication date

Subjects

Access